Global Trends in Cardiovascular Mortality and Major Cardiometabolic Risk Factors, 2000 to 2023: A Longitudinal Ecological Analysis of 204 Countries and Territories
- 1Amran university
Abstract
Background and AimsCardiovascular disease (CVD) remains the leading cause of global mortality. We evaluated 24-year global trends in age-standardized CVD mortality across 204 countries and territories (2000-2023) and decomposed the independent longitudinal associations of major cardiometabolic risk factor pathways.
MethodsThe study analyzed a balanced panel of 4,896 country-year observations using Global Burden of Disease 2023 and World Bank data. Two-way fixed-effects panel regression models adjusting for country fixed effects, year fixed effects, GDP per capita, and urbanization were specified using Driscoll-Kraay robust standard errors. Hierarchical path mediation and extended 1- to 10-year lag models evaluated risk pathways and disease latency.
ResultsGlobal age-standardized CVD mortality declined from 340.2 {+/-} 156.4 to 258.4 {+/-} 132.1 deaths per 100,000 population (2000-2023), but annual declines stagnated post-2019 (-1.31% to -0.03% per year). High SBP (adjusted beta = 1.129), high LDL cholesterol (beta = 0.622), smoking (beta = 0.452), and high fasting glucose (beta = 0.410) were independently associated with CVD mortality (P < 0.001 for all). High SBP reduction accounted for 70.91% of the global mortality decline. High BMI was not directly associated with mortality (beta = 0.049, P = 0.421); mediation analysis proved that 99.20% of its population impact is mediated through downstream metabolic intermediaries.
ConclusionsElevated SBP and cumulative LDL cholesterol are the primary drivers of global cardiovascular mortality. Obesity acts as an upstream driver operating almost entirely through downstream metabolic intermediaries. Sustained progress requires prioritizing universal blood pressure control, lipid lowering, and multi-sectoral obesity prevention.
Related
- Remnant-cholesterol-inflammatory-index as a novel predictor of cardiometabolic risk and cardiovascular mortality in elderly patients with severe aortic stenosis
- Atrial Cardiomyopathy Refines Cardiovascular Mortality Risk Across Cardiometabolic Risk Factor Burden
- Estimated glucose disposal rate shows the broadest associations with cardiometabolic multimorbidity progression in early cardiovascular–kidney–metabolic stages: a longitudinal cohort study
- Cardiovascular disease mortality in a Central-West Brazilian capital: A spatial, temporal, and ecological analysis
- Associations of access to exercise opportunities and physical inactivity with cardiovascular–kidney–metabolic mortality: a nationwide ecological study
BibTeX
@misc{aldhayani2026global,
title = {{Global Trends in Cardiovascular Mortality and Major Cardiometabolic Risk Factors, 2000 to 2023: A Longitudinal Ecological Analysis of 204 Countries and Territories}},
author = {K. M. Al-Dhayani},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.14.26363013},
url = {https://www.medrxiv.org/content/10.64898/2026.09.14.26363013v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Global Trends in Cardiovascular Mortality and Major Cardiometabolic Risk Factors, 2000 to 2023: A Longitudinal Ecological Analysis of 204 Countries and Territories
AU - K. M. Al-Dhayani
PY - 2026
DA - 2026/09/14
PB - medRxiv
DO - 10.64898/2026.09.14.26363013
UR - https://www.medrxiv.org/content/10.64898/2026.09.14.26363013v1
AB - Background and AimsCardiovascular disease (CVD) remains the leading cause of global mortality. We evaluated 24-year global trends in age-standardized CVD mortality across 204 countries and territories (2000-2023) and decomposed the independent longitudinal associations of major cardiometabolic risk factor pathways. MethodsThe study analyzed a balanced panel of 4,896 country-year observations using Global Burden of Disease 2023 and World Bank data. Two-way fixed-effects panel regression models adjusting for country fixed effects, year fixed effects, GDP per capita, and urbanization were specified using Driscoll-Kraay robust standard errors. Hierarchical path mediation and extended 1- to 10-year lag models evaluated risk pathways and disease latency. ResultsGlobal age-standardized CVD mortality declined from 340.2 {+/-} 156.4 to 258.4 {+/-} 132.1 deaths per 100,000 population (2000-2023), but annual declines stagnated post-2019 (-1.31% to -0.03% per year). High SBP (adjusted beta = 1.129), high LDL cholesterol (beta = 0.622), smoking (beta = 0.452), and high fasting glucose (beta = 0.410) were independently associated with CVD mortality (P < 0.001 for all). High SBP reduction accounted for 70.91% of the global mortality decline. High BMI was not directly associated with mortality (beta = 0.049, P = 0.421); mediation analysis proved that 99.20% of its population impact is mediated through downstream metabolic intermediaries. ConclusionsElevated SBP and cumulative LDL cholesterol are the primary drivers of global cardiovascular mortality. Obesity acts as an upstream driver operating almost entirely through downstream metabolic intermediaries. Sustained progress requires prioritizing universal blood pressure control, lipid lowering, and multi-sectoral obesity prevention.
ER -